Peer Review History
| Original SubmissionMarch 23, 2020 |
|---|
|
PONE-D-20-08357 “Dispense Antiretrovirals daily!” Restructuring delivery of HIV services to optimize antiretroviral initiation among men in Malawi. PLOS ONE Dear Dr. Nyondo-Mipando, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Jeremiah Chikovore Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript addresses the important topic of barriers to ART initiation and adherence among men in Malawi. The manuscript is technically sound, but errors in the English and choppy sentence structure make comprehension difficult at times and interrupt the flow of the manuscript. The manuscript would benefit from heavy editing from a professional editor both in terms of English grammar and organization (flow from one sentence/topic to another; particularly in the introduction and discussion sections). The methods section is well-developed according to COREQ guidelines. Information about ethical approval should also be included in the body of the manuscript, in the methods section. Line 240: Why were all data collectors female? How might that have affected data collection? In the data analysis section, it would be interesting to provide examples of the thematic codes used. Lines 489-495: Includes a quote that was included elsewhere. Lines 508-515: It would be helpful to explain what the role of a guardian is in Malawi. Given that men of unknown status, HIV-positive men on ARTs and HIV-positive men not on ARTs were sampled, it would be interesting to note whether there were differences in the insights obtained from each category of men. Given that the study was conducted in 2017, it would be helpful to explicitly discuss how relevant the findings are in 2020. Has Malawi already rolled-out policy changes that address any of the study's recommendations? If so, is there any evidence that those policy changes have improved uptake of timely and continuous ART by men in Malawi? Regarding data availability, there are many participant quotes in the manuscript, but the authors could also make the de-identified transcripts or excerpts of transcripts reflecting the thematic codes underlying the manuscript available on a public data repository. Reviewer #2: The paper ‘Dispense Antiretrovirals daily!’ Restructuring delivery of HIV services to optimize ART initiation among men in Malawi is a qualitative study that evaluates the existing health services for men in Blantyre, Malawi. This paper fits into the small but important body of literature from SSA that focuses on HIV service provision for men, a relatively under-researched topic within the HIV literature. This qualitative paper is containing findings from an extensive study for which the research team interviewed a range of different health workers and male patients recruited from 7 different clinics in the city. I applaud the authors for being able to get so many rich findings, but unfortunately, I have to reject the paper. Below, I will outline the reasons why I made this decision and will give some ideas on how to move forward. Firstly, the structure of the background and the rest of the paper is not consistent. In the background, a brief overview of the problem at hand is given, but there is little description on how the services are structured within the area, what exact services are offered per clinic and how these clinics work organisationally. This is key for the rest of the paper. Ideas around stigma and other barriers to care for men are mentioned, but not adequately unpacked, even though many of the findings point towards stigmatization of men when they come to the clinic. This is a missed opportunity. Then, the methods is too long and too descriptive, and could be shorter. However, this can be done through thorough restructuring and proofreading of the paper. In the results, I wanted to congratulate the authors with being able to recruit 15 male health workers, and I was looking forward to reading their remarks on male patient’s behaviours, but this was not provided in detail. Some of the findings section (1.1) were really long, and the quotes were not explained/contextualised within a structured narrative. Others were really short and provided little detail. There are several mentions of ‘a guardian’, even though I thought only men of 18 and above were recruited, which was confusing. A summary of the findings would have been useful and when reading the different sections, I would provide more details on how you interpreted the findings. I would also restructure the paragraphs and re-analyse part of the data, as some quotes are repetitive. I would definitely include a section on Stigma, and on Health System barriers. In the discussion, little reference is made to existing strategies for men and little advise if given for implementing changes for future practice. In summary, I think this paper could improve drastically if the authors worked with an independent writing advisor to restructure this paper, as I think the authors put in an incredible amount of work in getting the data and on this important topic. Overall editing is also encouraged to improve the paper. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Myrna van Pinxteren [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-08357R1 “Dispense Antiretrovirals daily!” Restructuring the delivery of HIV services to optimize antiretroviral initiation among men in Malawi. PLOS ONE Dear Dr. Nyondo-Mipando, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 11 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Jeremiah Chikovore Academic Editor PLOS ONE Additional Editor Comments (if provided): Thank you for submitting a revised version of your manuscript. The feedback from reviewers is that, overall the article has improved. However, we cannot accept the article in its current form. Please address all of the reviewers’ concerns fully. A message that comes through from the reviews is that the article still needs to be edited for flow, grammar, consistency, and redundancies. Whereas one of our reviewers has considered helping with editing, the journal determines rather that this editing be pursued independently by yourselves as authors. Kindy note that PLOS partners with Editage for purposes of editing and would be happy to connect you to this service, while you are also free to use whichever resources you prefer. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the revision. The manuscript is much improved, but it still requires a careful edit to improve the English and the flow, facilitate comprehension and to make it as succinct as possible/eliminate redundancies. With substantial editing, I believe it would be fit to publish as the methodology is solid and the results interesting. I began making suggested edits, but it became too time consuming to continue in this way: Lines 89-91: There are two ideas presented in this sentence, but I'm not sure that one follows from the other: The services are also biased towards females (21) such that projects among men have primarily focused on men having sex with men (MSM) (22,23). Line 115: ARVs instead of ARVS Line 150: Delete the second "rate": Blantyre district has the highest prevalence rate of HIV among men at 14% as of... Line 154: IDIs instead of IDIS Lines 155-157: The following sentence is vague; consider rephrasing or deleting: We deliberately sampled men of varying HIV statuses to gather perceptions of all characteristics of men to ensure wider coverage of our findings. Line 176: Consider changing "after sharing the study and its eligibility, the facility In-charge" to "after explaining the study and the eligibility criteria, the Officer In-charge assisted with the identification of..." Lines 186-191: I would rephrase as: "We included heterosexual men (as ascertained by asking them their sexual orientation) who were 18 years of age and above, able and willing to provide consent, and of a range of HIV statuses: uninfected (confirmed through checking the health passport books), unknown (ascertained by asking if they have ever tested for HIV or not), and HIV infected on ART and not on ART (confirmed through checking the health passport book and/or clinic records)." Line 191: There are places where you are using "facility In-charge" where I think you may mean "Officer In-charge"? Line 207: "assistance from HCWs" instead of "assistance for" Lines 208-211: Split into two sentences: We included men that were 18 years and above, varying HIV status, on ARVs and not on ARVs, able to provide consent, and willing to participate in the study. These men were identified in the departments within the clinic and the communities around each health facility. Lines 211-212: I would rephrase as: "Men were scheduled for a discussion at a time and place convenient for them." Lines 219-220: I would rephrase as: With the exception of VM, all authors conducted interviews and all data collectors were female." Line 220: I would add: "Before data collection, ALNM, the Principal Investigator (PI) trained..." Line 221-225: I would rephrase as: "LSK and SS are public health specialists with Masters in Public health. TK has a Bachelor of Nursing and Midwifery and ALNM has a PH.D. in Health Systems and Policy." Line 230: Replace "shared of her past research" with "shared her past research" Line 234: add an "s" to question Lines 235-238: Were these the broad questions for everyone or just for health care workers? Please clarify. Lines 246-250: This sentence is a bit choppy and unclear. Line 251: Replace "in a language" with "in the language" Line 260: NVivo instead of NVIvo Lines 263-265: Suggest rephrasing as: Codes were generated, deductively, from the objectives of the study and also, inductively, from the data. Lines 265-267: Suggest editing to: "First, the Principal Investigator listened to the audios and read the transcripts multiple times to gain a deeper understanding of the issues raised" Table 1: Overall, the table is a bit confusing and needs improvement. I suggest adding a column for percentages as well as for counts. In terms of education level, those who did not have a primary school education had no education? Or more than a primary school education? Perhaps it would be clearer to show each of the different levels of education represented. Uptake of ARVs is only relevant for those who are HIV-positive, not the full sample of 131 participants, so it is difficult to interpret. Table 2: Make it clear that the table summarizes the key findings. The discussion section and conclusion require editing and focus to improve comprehension and retention of the key contributions of the manuscript. Reviewer #2: Comments for the authors: Thank you so much for giving me the opportunity to review this paper. The structure and writing of this paper has been drastically improved compared to the previous draft. However, I still am of the opinion that the methods section and section 1.1 in the findings is too detailed and can be shortened for readability in the paper. I have also given some suggestions for further readings for the discussion section. Lastly, I would urge the authors to get a professional editor to proofread the publication for grammar, spelling and overall readability of the paper. Please see more detailed comments below. These comments can be addressed with the assistance of the editor. Introduction: For the following statements, there is there no reference, not even a webpage, health report or policy brief. ‘The implementation of these services must be based on evidence and this is important for your paper However, anecdotal reports show that some health implementing partners piloted male-friendly clinic services in 12 primary health facilities in Blantyre, Malawi in 2018, a year after we had finalized data collection.’ The implementation of these services must be based on evidence and this is important for your paper. Methods: I am still of the opinion that this section is too long and detailed. Although your comment suggest that this is the first publication from the project, it is not a description of the project or M&E paper, therefore there is no need to describe the data collection processes in too much detail. A few more points below which can help you to condense the method section: a) References on in-depth interviews and other data collection methods are missing (line 131). Identification of participants (both patients and health care workers) for IDI’s and FGD’s could be summarized further. You are loosing the reader here. b) Data analysis can be further summarized too, the process is interesting, but written to extensively. take out for instance the following sentence: ‘We examined each code for further subcategories (40) to ensure that each related concept is grouped under one category and we dropped themes that were not broad enough, for instance, we had a theme on male-specific clinics which we later grouped under clinic operations because it was closely related to that.’ (line 282 – 284) Findings: I still believe that section one of the findings can be shortened, to improve the flow and structure of the article. Paragraph 1.1 contains too many quotes which makes it too repetitive. Pick a few good ones to make your argument and move on to the next paragraph. Also, be very clear about the description of participants and be consistent. The first quote starting on line 365, states ‘younger men FGD participant at Centre 2’. This sentence is incorrect, unless you are quoting 2 men. I would change it to; ‘Male participant FGD at Centre 2’. This is done throughout the article. Also, is it relevant to know if the participant is infected with HIV or not? And are they honest about it? I would take that out of the descriptions of the quotes as done in line 380. At line 390 of the findings, again the description of the health care worker is different, here you say ‘KII, HDA at Centre 3’, please be specific or explain the acronyms at the start of the findings. This is about consistency. In Paragraph 1.2, you want to make a clearer connection between the different paragraphs and signpost the reader. An example from line 450, you can add; ‘in addition to dispensing ARV’s on a daily basis, participants also suggested longer opening times for clinics to accommodate work schedules of men.’ The same goes for other paragraphs in the findings section. Although this part needs editing and further proofreading, the analysis of the findings and unpacking of the quotes has definitely improved throughout the findings. Discussion: Stigmatization and HIV services has been unpacked accurately in the discussion section. There is a missing reference after the sentence in line 722. The paragraph starting on line 736 gives a good indication of why ARV’s need to be dispensed not per month, but per 3 or 6 months. But there is a need to include that this only works with patients who are stable on ARV’s. In South Africa, stable means being on treatment uninterrupted for at least six months. Another angle to explore can be pill-fatigue, a concept that has come up in similar conversations we had in our research project. Providing treatment for 6 months can prevent pill-fatigue among patients which can lead to non-adherence. The paragraph starting on line 747 speaks about dispensary of ARV’s in other places than a pharmacy. Here, you can link effectively to studies conducted in South Africa with adherence clubs that meet patients outside of clinic spaces. Medication gets dispensed in community centres or churches, which means patients don’t have to wait in queues, have more freedom and keep their confidentiality. I think referring to some of these studies will improve the discussion section of the paper. Conclusion: I would suggest not to start with a statement about HIV stigma and services for men, as this was not the focus of your paper. The focus of your paper is how health services can be better tailored for the needs of men. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Myrna van Pinxteren [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-20-08357R2 “Dispense Antiretrovirals daily!” Restructuring the delivery of HIV services to optimize antiretroviral initiation among men in Malawi. PLOS ONE Dear Dr. Nyondo-Mipando, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 19 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Jeremiah Chikovore Academic Editor PLOS ONE Additional Editor Comments (if provided): Please may you address the following additional queries. - Line 33-35: Please remove capital letters in the phrases ‘in-depth interviews’, ‘focus group discussions’, ‘health care workers.’ - Line 36: Please remove ‘were’. - Please check all places where ‘Initiation of antiretroviral drugs’ or similar is mentioned. I would presume it is ‘initiation of antiretroviral treatment’ rather than initiation of drugs. - Please define ‘ART’, ‘ARVs’ at first use, including in abstract - Line 39: Please check the sentence in abstract “Restructuring the delivery and conduct of ART clinics”. Do you intend to imply that ART clinics are delivered? - Line 43-44. Consider restructuring/punctuating the sentence to enhance logic and ideas flow. It is not easy to understand specifically how ‘removing of other structural barrier’ links into the whole sentence. - Line 45-46: ‘Implementation of test and treat strategy’. I think this phrase could be qualified – is test and treat not being implemented in these facilities/in Malawi? - Line 39-40. This seems to belong to the conclusion. - The abbreviation MSM, unless used twice or more, may not need to be included - consider leaving only as ‘men having sex with men’. - Table 1 revision -please consider moving the absolute number (N=133) from the middle column to percentages column; and have % (N=133); this might read better, if acceptable to the authors. - Table 1: Please also insert a line in the left column, dividing the age and marital status cells - Line 771: I suggest writing ‘pharmacy’ in small caps - Table 1: Please align all numbers appropriately – as is done in the rows for education, and uptake of ARVs, for example - Table 1. “HIV testing’ is written twice - Discussion – Please review and consolidate any points likely repeated between para 1 and para 2; I see what appears repeated reference to integration. Kindly check again - The reference to hegemony masculinities - Please confirm that this is the term intended, and that it is how the cited author names it? - Table 2: Last line, please remove ‘on’ after ‘emphasizes’ - Table 2: Please remove capital letters where these are not needed in the table text - Please also remove capital letters where they are not needed in headings and sub-titles Regarding the following query from the authors, please see Academic Editor’s recommendation. - Reviewer 2: Also, is it relevant to know if the participant is infected with HIV or not? And are they honest about it? I would take that out of the descriptions of the quotes as done in line 380. Response: This kind of identification was brought it after round 1 review. We now need further direction whether this has to be dropped or left as it is. - The Academic Editor reviewed the authors’ response in the first revision and understood that the authors felt including HIV status provided context to the quotes. It is suggested that the authors may retain HIV status but indicate (maybe in the methods section) how this status was determined and any possible limitations, e.g. whether they are confident the HIV status report is authentic. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
“Dispense Antiretrovirals daily!” Restructuring the delivery of HIV services to optimize antiretroviral initiation among men in Malawi. PONE-D-20-08357R3 Dear Dr. Nyondo-Mipando, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Jeremiah Chikovore Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-08357R3 “Dispense Antiretrovirals daily!” Restructuring the delivery of HIV services to optimize antiretroviral initiation among men in Malawi. Dear Dr. Nyondo-Mipando: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Jeremiah Chikovore Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .